UNSPSC 51372602: Enadoline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51372602

Definition

This classification denotes an opioid receptor agonist with the molecular formula C24H32N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KJL283326C, chemically known as 4-benzofuranacetamide, n-methyl-n-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-, (5r-(5alpha,7alpha,8beta))- but generally known as enadoline, which bears US NIH Compound Identifier 60768. European Medicines Agency schedules Enadoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06513MIG.

Read the full definition

The term ENADOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ENADOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enadoline under HS 29349990 and SITC 51579. As of Q4 2014, ENADOLINE remains the US FDA Preferred Term for this commodity. Enadoline bears US NLM identifiers UMLS ID C0209582 and NCI Concept Code C80576. SMILES: O1C2(CC(N3CCCC3)C(N(C)C(=O)CC3C4C(OCC4)CCC3)CC2)CCC1.

About UNSPSC 51372602

UNSPSC 51372602 Enadoline, a Commodity code, covers naloxone and pharmaceutical products procured by state and local health agencies and cooperative purchasing alliances for community health initiatives, emergency response, and pharmacy benefit programs. State and local governments use this code to acquire naloxone units, drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing arrangements. Issuing bodies span county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that serve state agencies, local governments, and healthcare facilities across multiple jurisdictions.

Recent activity includes Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023, with quarterly deliveries to the county community health building); the Texas Health and Human Services Commission's RFI regarding direct-to-manufacturer prescription programs under its Therapeutic Pharmacy Initiative (posted April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon (due March 26, 2026, with contract effectiveness July 1, 2026). Vendors responding to these opportunities must comply with drug supply chain security requirements, FDA regulations, current Good Manufacturing Practices, E-Verify employment verification, workers' compensation and liability insurance, and in cooperative arrangements, maintenance of relationships with authorized wholesalers and submission of detailed product information including National Drug Codes and pricing in designated formats. Geographic spread includes Florida, Texas, Minnesota, and Oregon, with activity concentrated in state health departments and multistate cooperative purchasing vehicles.

Quick answers

What is UNSPSC 51372602?

UNSPSC 51372602 is Enadoline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51372602?

UNSPSC 51372602 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51372602

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code